|
May 2
|
Compared to Estimates, AtriCure (ATRC) Q1 Earnings: A Look at Key Metrics
|
|
May 1
|
AtriCure Inc (ATRC) Surpasses Revenue Estimates in Q1 2024 Despite Wider Losses
|
|
May 1
|
AtriCure (ATRC) Reports Q1 Loss, Tops Revenue Estimates
|
|
May 1
|
AtriCure Reports First Quarter 2024 Financial Results
|
|
Apr 30
|
AtriCure to Participate in the 2024 Bank of America Securities Healthcare Conference
|
|
Apr 19
|
AtriCure's (ATRC) cryoSPHERE+ Probe to Aid in Pain Management
|
|
Apr 18
|
AtriCure Announces Launch of the cryoSPHERE®+ Probe for Post-Operative Pain Management
|
|
Apr 10
|
AtriCure to Announce First Quarter 2024 Financial Results
|
|
Mar 26
|
AtriCure to Participate in the 23rd Annual Needham Virtual Healthcare Conference
|
|
Mar 22
|
AtriCure (ATRC) Declined due to Concerns Over Anti-Obesity Drug
|
|
Mar 7
|
Chief Legal Officer Karl Dahlquist Sells 8,231 Shares of AtriCure Inc (ATRC)
|
|
Dec 20
|
AtriCure to Participate in the 42nd Annual J.P. Morgan Healthcare Conference
|
|
Sep 11
|
Unveiling AtriCure (ATRC)'s Value: Is It Really Priced Right? A Comprehensive Guide
|